What is the Atogepant?

Atogepant is , while it's Molecular Formula is C29H23F6N5O3. Used in Migraine Management: Atogepant is used as a preventive treatment for migraines, aiming to reduce the frequency and severity of migraine attacks. It is being studied as a once-daily oral medication, providing a potential new option for patients who suffer from frequent migraines and are in need of preventive treatment. The drug has shown promising results in clinical trials, demonstrating its efficacy in managing this debilitating condition.

What is the CAS number for Atogepant?

The CAS number of Atogepant is 1374248-81-3.

What is Atogepant (1374248-81-3) used for?

Atogepant is a small molecule calcitonin gene-related peptide (CGRP) receptor antagonist that is being developed for the preventive treatment of migraine. It works by blocking the CGRP receptor, which is involved in the transmission of pain signals in the brain and is believed to play a role in the development of migraines. Its development marks an important advancement in the field of migraine management, offering a potential new treatment option for the millions of individuals affected by this debilitating condition.

What is the Atogepant?

Atogepant is , while it's Molecular Formula is C29H23F6N5O3. Used in Migraine Management: Atogepant is used as a preventive treatment for migraines, aiming to reduce the frequency and severity of migraine attacks. It is being studied as a once-daily oral medication, providing a potential new option for patients who suffer from frequent migraines and are in need of preventive treatment. The drug has shown promising results in clinical trials, demonstrating its efficacy in managing this debilitating condition.

What is the CAS number for Atogepant?

The CAS number of Atogepant is 1374248-81-3.

What is Atogepant (1374248-81-3) used for?

Atogepant is a small molecule calcitonin gene-related peptide (CGRP) receptor antagonist that is being developed for the preventive treatment of migraine. It works by blocking the CGRP receptor, which is involved in the transmission of pain signals in the brain and is believed to play a role in the development of migraines. Its development marks an important advancement in the field of migraine management, offering a potential new treatment option for the millions of individuals affected by this debilitating condition.

Product classification

Hormones and steriods major pro

Medroxyprogesterone acetate intermediates

Progesterone intermediate

Cyproterone acetate intermediate

Deflazacort intermediate

Desogestrel intermediate

Finasteride intermediate

Steroid & Hormone Products
Major Products

Rocuronium bromide intermediate

Ubrogepant intermediate

Rimegepant intermediate

Indacaterol intermedaite

Dapagliflozin intermediate

Pharmaceutical Products

Other
Others

Contact us

Tel： +86-0571-86066502

Fax：+86-571-85106883

Phone：18958062155

Website：https://www.zjgoldpharm.com

Email：sales@zjgoldpharm.com

Address：Xixi Century Zone, Xihu, District, Hangzhou, Zhejiang, China

1374248-81-3

Product Name：Atogepant
Molecular Formula：C29H23F6N5O3
Purity：99%
Molecular Weight：603.5

Inquiry Add to cart

Product Details;

CasNo： 1374248-81-3

Molecular Formula： C29H23F6N5O3

Factory Sells Best Quality Atogepant 1374248-81-3 with GMP standards

Molecular Formula:C29H23F6N5O3
Molecular Weight:603.5

Relevant Products

Voriconazole
CAS：137234-62-9
Loratinib
CAS：1454846-35-5
Etonogestrel
CAS：54048-10-1

Medroxyprogesterone Acetate

Eplerenone

Dydrogesterone

Cyproterone Acetate

Hydroxyprogesterone Caproate

Home

About us

Products

Hormones and steriods major pro

Major Products

Others

Technical support

News

Join us

Contact Us

Pharmaceutical Products

Product classification

Medroxyprogesterone acetate intermediates

Progesterone intermediate

Cyproterone acetate intermediate

Deflazacort intermediate

Desogestrel intermediate

Finasteride intermediate

Steroid & Hormone Products

Rocuronium bromide intermediate

Ubrogepant intermediate

Rimegepant intermediate

Indacaterol intermedaite

Dapagliflozin intermediate